Bifurcations and Chaotic Dynamics in a Tumour-Immune-Virus System

Despite mounting evidence that oncolytic viruses can be effective in treating cancer, understanding the details of the interactions between tumour cells, oncolytic viruses and immune cells that could lead to tumour control or tumour escape is still an open problem. Mathematical modelling of cancer oncolytic therapies has been used to investigate the biological mechanisms behind the observed temporal patterns of tumour growth. However, many models exhibit very complex dynamics, which renders them difficult to investigate. In this case, bifurcation diagrams could enable the visualisation of model dynamics by identifying (in the parameter space) the particular transition points between different behaviours. Here, we describe and investigate two simple mathematical models for oncolytic virus cancer therapy, with constant and immunity-dependent carrying capacity. While both models can exhibit complex dynamics, namely fixed points, periodic orbits and chaotic behaviours, only the model with immunity-dependent carrying capacity can exhibit them for biologically realistic situations, i.e., before the tumour grows too large and the experiment is terminated. Moreover, with the help of the bifurcation diagrams we uncover two unexpected behaviours in virus-tumour dynamics: (i) for short virus half-life, the tumour size seems to be too small to be detected, while for long virus half-life the tumour grows to larger sizes that can be detected; (ii) some model parameters have opposite effects on the transient and asymptotic dynamics of the tumour.

[1]  R. Coffin Oncolytic immunotherapy: an emerging new modality for the treatment of cancer. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  Ivo P. Janecka,et al.  Cancer control through principles of systems science, complexity, and chaos theory: A model , 2007, International journal of medical sciences.

[3]  H. Atkins,et al.  Targeted inflammation during oncolytic virus therapy severely compromises tumor blood flow. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[4]  L. Glass,et al.  Oscillation and chaos in physiological control systems. , 1977, Science.

[5]  L. D. Pillis,et al.  A Validated Mathematical Model of Cell-Mediated Immune Response to Tumor Growth , 2005 .

[6]  S. Russell,et al.  PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized Mice , 2013, Journal of Virology.

[7]  H. Pircher,et al.  On the role of antigen in maintaining cytotoxic T-cell memory. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[8]  T. Pham,et al.  Spatial chaos and complexity in the intracellular space of cancer and normal cells , 2013, Theoretical Biology and Medical Modelling.

[9]  A. Radunskaya,et al.  A Model of Dendritic Cell Therapy for Melanoma , 2013, Front. Oncol..

[10]  Dominik Wodarz,et al.  Towards Predictive Computational Models of Oncolytic Virus Therapy: Basis for Experimental Validation and Model Selection , 2009, PloS one.

[11]  A. Wolf,et al.  Determining Lyapunov exponents from a time series , 1985 .

[12]  G. Nicolson,et al.  Experimental Brain Metastasis , 1980 .

[13]  E. Lorenz Deterministic nonperiodic flow , 1963 .

[14]  M. Quinn,et al.  CRP identifies homeostatic immune oscillations in cancer patients: a potential treatment targeting tool? , 2009, Journal of Translational Medicine.

[15]  J. Holland,et al.  The intracellular half-lives of nonreplicating nucleocapsids of DI particles of wild type and mutant strains of vesicular stomatitis virus. , 1986, Virology.

[16]  Urszula Ledzewicz,et al.  AntiAngiogenic Therapy in Cancer Treatment as an Optimal Control Problem , 2007, SIAM J. Control. Optim..

[17]  N. Rashevsky,et al.  Mathematical biology , 1961, Connecticut medicine.

[18]  J. Bell,et al.  Recent progress in the battle between oncolytic viruses and tumours , 2005, Nature Reviews Cancer.

[19]  R. Vile,et al.  Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling , 2011, Gene Therapy.

[20]  M. Bevan,et al.  Effector and memory CTL differentiation. , 2007, Annual review of immunology.

[21]  J A Sherratt,et al.  Modelling the macrophage invasion of tumours: effects on growth and composition. , 1998, IMA journal of mathematics applied in medicine and biology.

[22]  Joanna R. Wares,et al.  Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics. , 2015, Mathematical biosciences and engineering : MBE.

[23]  F. Carraro,et al.  Role of inflammatory mediators in angiogenesis. , 2005, Current drug targets. Inflammation and allergy.

[24]  H. Pircher,et al.  Solid tumors “melt” from the inside after successful CD8 T cell attack , 2006, European journal of immunology.

[25]  Natalia L. Komarova,et al.  Complex Spatial Dynamics of Oncolytic Viruses In Vitro: Mathematical and Experimental Approaches , 2012, PLoS Comput. Biol..

[26]  Helen M. Byrne,et al.  Macrophage-tumour interactions: in vivo dynamics , 2003 .

[27]  Miguel A F Sanjuán,et al.  A Validated Mathematical Model of Tumor Growth Including Tumor–Host Interaction, Cell-Mediated Immune Response and Chemotherapy , 2014, Bulletin of Mathematical Biology.

[28]  C. J. Gordon,et al.  Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature , 2013, Proceedings of the National Academy of Sciences.

[29]  Svetlana Bunimovich-Mendrazitsky,et al.  Mathematical Model of BCG Immunotherapy in Superficial Bladder Cancer , 2007, Bulletin of mathematical biology.

[30]  M. Wicha,et al.  Cancer stem cells: a step toward the cure. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  James D. Murray Mathematical Biology: I. An Introduction , 2007 .

[32]  P. Beverley Primer: making sense of T-cell memory , 2008, Nature Clinical Practice Rheumatology.

[33]  A. Dalgleish,et al.  The relevance of non-linear mathematics (chaos theory) to the treatment of cancer, the role of the immune response and the potential for vaccines. , 1999, QJM : monthly journal of the Association of Physicians.

[34]  Mads Kærn,et al.  Model-based rational design of an oncolytic virus with improved therapeutic potential , 2013, Nature Communications.

[35]  Zeljko Bajzer,et al.  Modeling of cancer virotherapy with recombinant measles viruses. , 2008, Journal of theoretical biology.

[36]  Z Bajzer,et al.  Dynamics of multiple myeloma tumor therapy with a recombinant measles virus , 2009, Cancer Gene Therapy.

[37]  Dominik Wodarz,et al.  Computational modeling approaches to studying the dynamics of oncolytic viruses. , 2013, Mathematical biosciences and engineering : MBE.

[38]  B. Benacerraf,et al.  Blood clearance of P32-labeled vesicular stomatitis and Newcastle disease viruses by the reticuloendothelial system in mice. , 1960, Journal of immunology.

[39]  L A Aguirre,et al.  What can be learned from a chaotic cancer model? , 2013, Journal of theoretical biology.

[40]  R. Kratzke,et al.  Oncolytic virus therapy for cancer: the first wave of translational clinical trials. , 2013, Translational research : the journal of laboratory and clinical medicine.

[41]  Lawrence M Wein,et al.  Validation and analysis of a mathematical model of a replication-competent oncolytic virus for cancer treatment: implications for virus design and delivery. , 2003, Cancer research.

[42]  S. Boccaletti,et al.  The control of chaos: theory and applications , 2000 .

[43]  S. Rosenberg,et al.  Cancer immunotherapy: moving beyond current vaccines , 2004, Nature Medicine.

[44]  S. Russell,et al.  ONCOLYTIC VIROTHERAPY , 2012, Nature Biotechnology.

[45]  D. Earn,et al.  Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma. , 2010, Journal of theoretical biology.

[46]  D. Wodarz,et al.  Viruses as antitumor weapons: defining conditions for tumor remission. , 2001, Cancer research.

[47]  Y. Soini,et al.  A high number of tumor-infiltrating lymphocytes are associated with a small tumor size, low tumor stage, and a favorable prognosis in operated small cell lung carcinoma. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[48]  R. Ahmed,et al.  Models of immune memory: on the role of cross-reactive stimulation, competition, and homeostasis in maintaining immune memory. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J S Spratt,et al.  Decelerating growth and human breast cancer , 1993, Cancer.

[50]  Eleanor Pullenayegum,et al.  Potentiating cancer immunotherapy using an oncolytic virus. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[51]  T. Mattfeldt Nonlinear deterministic analysis of tissue texture: a stereological study on mastopathic and mammary cancer tissue using chaos theory , 1997, Journal of microscopy.

[52]  G. Silvestri,et al.  Differential innate immune responses to low or high dose oral SIV challenge in Rhesus macaques. , 2011, Current HIV research.

[53]  A. Mackensen,et al.  Effector function of human tumor-specific CD8 T cells in melanoma lesions: a state of local functional tolerance. , 2004, Cancer research.

[54]  S. Friberg,et al.  REVIEW ARTICLE On the Growth Rates of Human Malignant Tumors: Implications for Medical Decision Making , 1997 .

[55]  D. Earn,et al.  Interactions Between the Immune System and Cancer: A Brief Review of Non-spatial Mathematical Models , 2011, Bulletin of mathematical biology.

[56]  F. Wong-Staal,et al.  Oncolytic virotherapy as a personalized cancer vaccine , 2008, International journal of cancer.

[57]  Philip Hahnfeldt,et al.  Modeling the Dichotomy of the Immune Response to Cancer: Cytotoxic Effects and Tumor-Promoting Inflammation , 2013, Bulletin of mathematical biology.

[58]  L. Wein,et al.  Modeling and analysis of a virus that replicates selectively in tumor cells , 2001, Bulletin of mathematical biology.

[59]  P. Hahnfeldt,et al.  Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and postvascular dormancy. , 1999, Cancer research.

[60]  G. Kobinger,et al.  PEGylation of a Vesicular Stomatitis Virus G Pseudotyped Lentivirus Vector Prevents Inactivation in Serum , 2004, Journal of Virology.

[61]  D L S McElwain,et al.  A history of the study of solid tumour growth: The contribution of mathematical modelling , 2004, Bulletin of mathematical biology.

[62]  B. Ovbiagele,et al.  Drug Insight: translating evidence on statin therapy into clinical benefits , 2008, Nature Clinical Practice Neurology.

[63]  H. Schreiber,et al.  Innate and adaptive immune cells in the tumor microenvironment , 2013, Nature Immunology.

[64]  D. Kirschner,et al.  Modeling immunotherapy of the tumor – immune interaction , 1998, Journal of mathematical biology.

[65]  Jonathan Dushoff,et al.  Multi-Stability and Multi-Instability Phenomena in a Mathematical Model of Tumor-Immune-Virus Interactions , 2011, Bulletin of mathematical biology.

[66]  R. Labianca,et al.  Evidence for cure by adjuvant therapy in colon cancer: observations based on individual patient data from 20,898 patients on 18 randomized trials. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[67]  K. Pienta,et al.  Cancer as a complex adaptive system. , 1996, Medical hypotheses.

[68]  D. Schaffer,et al.  Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectors , 2013, Gene Therapy.